Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | CAD | P27708 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27299232 | 0.89 | LMNA (0.50) | LMNAALDH1A1HSD17B10MAPTKDM4E | |
| SCHEMBL1332017 | 0.89 | LMNA (0.53) | LMNAALDH1A1HSD17B10MAPTKDM4E | |
| SCHEMBL1332187 | 0.89 | LMNA (0.53) | LMNAALDH1A1HSD17B10MAPTKDM4E | |
| SCHEMBL1331748 | 0.89 | LMNA (0.53) | LMNAALDH1A1HSD17B10MAPTKDM4E | |
| SCHEMBL1330728 | 0.89 | LMNA (0.53) | LMNAALDH1A1HSD17B10MAPTKDM4E | |
| SCHEMBL81193 | 0.89 | LMNA (0.53) | LMNAALDH1A1HSD17B10MAPTKDM4E | |
| SCHEMBL27644110 | 0.88 | LMNA (0.50) | LMNAALDH1A1HSD17B10MAPTKDM4E | |
| Acetic Acid SCHEMBL27475348 | 0.88 | LMNA (0.49) | LMNAALDH1A1HSD17B10MAPTKDM4E | |
| SCHEMBL3787404 | 0.87 | LMNA (0.51) | LMNAALDH1A1HSD17B10MAPTKDM4E | |
| Hydrochloric Acid SCHEMBL27898018 | 0.87 | LMNA (0.51) | LMNAALDH1A1HSD17B10MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108191909-B | Process for preparing glufosinate-ammonium acid by hydrogenation method | ATI化学国际公司 | 2020-05-01 | — | — | CN | claimed |
| US-20160031800-A1 | SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS AND INTERMEDIATES | VISTAGEN THERAPEUTICS, INC. | 2016-02-04 | — | — | US | claimed |
| EP-2970080-A1 | SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS AND INTERMEDIATES | Vistagen Therapeutics, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| CN-105164096-A | Synthesis of chiral kynurenine compounds and intermediates | VISTAGEN THERAPEUTICS INC | 2015-12-16 | — | — | CN | claimed |
| WO-2014152835-A1 | SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS AND INTERMEDIATES | VISTAGEN THERAPEUTICS, INC. (US) | 2014-09-25 | — | — | WO | claimed |
| US-4256641-A | ALKYL ALPHA-CARBOXAMIDOINDOLE-3-ACRYLATES MADE FROM 3-INDOLECARBOXALDEHYDES AND MONOALKYL CARBOXAMIDOMALONATES | HOFFMANN-LA ROCHE INC. (US) | 1981-03-17 | — | — | US | claimed |
| US-20240109848-A1 | PROCESS FOR THE PREPARATION OF IMIDAZOBENZODIAZEPINES | ODH IP Corp. (US) | 2024-04-04 | — | — | US | disclosed |
| WO-2024059669-A2 | IMPROVED PROCESS FOR THE PREPARATION OF IMIDAZOBENZODIAZEPINES | ODH IP Corp. (US) | 2024-03-21 | — | — | WO | disclosed |
| CN-110997654-B | Indole derivatives and uses thereof | 诺华股份有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-113121378-B | Synthesis method of acetamino diethyl malonate | 湖北宇阳药业有限公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-110938003-B | Preparation method of fingolimod hydrochloride | 新发药业有限公司 | 2022-11-22 | — | — | CN | disclosed |
| EP-3658546-B1 | INDOLE DERIVATIVES AND USES THEREOF | NOVARTIS AG (CH) | 2022-10-26 | — | — | EP | disclosed |
| CN-108069901-B | Novel rebamipide synthesis process | 重庆圣华曦药业股份有限公司 | 2020-12-11 | — | — | CN | disclosed |
| EP-0293062-A2 | Herbicidal composition | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-11-30 | — | — | EP | disclosed |
| CN-86100894-A | Process for the preparation of compounds | — | 1986-09-03 | — | — | CN | disclosed |
| US-4329343-A | ANTIARRYTHMIA AGENTS, BLOOD PLATELET ANTICOAGULANTS | SANOFI (FR) | 1982-05-11 | — | — | US | disclosed |
| US-4316847-A | ARTIFICIAL SWEETENING | HOFFMANN-LA ROCHE INC. (US) | 1982-02-23 | — | — | US | disclosed |
| US-4256641-A | ALKYL ALPHA-CARBOXAMIDOINDOLE-3-ACRYLATES MADE FROM 3-INDOLECARBOXALDEHYDES AND MONOALKYL CARBOXAMIDOMALONATES | HOFFMANN-LA ROCHE INC. (US) | 1981-03-17 | — | — | US | disclosed |
| US-4140697-A | ARTIFICIAL SWEETENER | HOFFMANN-LA ROCHE INC. (US) | 1979-02-20 | — | — | US | disclosed |
| US-4073795-A | Synthesis of tryptophans | HOFFMANN-LA ROCHE INC. (US) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109848-A1 | PROCESS FOR THE PREPARATION OF IMIDAZOBENZODIAZEPINES | CYP3A4, CYP3A5, CYP3A7 | LMNA 1306/4885ALDH1A1 576/4885HSD17B10 1498/4885 |
| US-20160031800-A1 | SYNTHESIS OF CHIRAL KYNURENINE COMPOUNDS AND INTERMEDIATES | KYNU, KMO, AADAT | LMNA 3707/4885ALDH1A1 2824/4885HSD17B10 934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.